Periodic Reporting for period 1 - HEPCAN (A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC))

Hepatocellular carcinoma (HCC) is the fastest rising and third leading cause of cancer related deaths worldwide (WHO IARC). Major causes include the hepatitis B and C viruses, alcoholism, Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. These medical...